Michael Rohr

Partner
Full contact info

I help technology and life sciences companies navigate the most critical stages of their lifecycle: formation, fundraising, growth and exit.

Experience

Tectonic Therapeutic Announces Merger With AVROBIO, $130.7 Million Private Financing Commitments

January 30, 2024

Cooley advised Tectonic Therapeutic, a privately held biotechnology company developing G-protein coupled receptor-targeted therapeutic proteins, on its definitive merger agreement to combine in an all-stock transaction with AVROBIO, a gene therapy company with a purpose to free people from a lifetime of genetic disease. Tectonic also obtained $130.7 million in private financing commitments with a syndicate of new and existing leading life sciences investors in connection with the merger.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Marc Recht
Partner, Boston
Courtney Thorne
Partner, Boston
Michael Rohr
Partner, Boston
Matthew Pavao
Partner, Boston
Nyron J. Persaud
Partner, New York
Phil Mitchell
Partner, New York
Chen Chen
Partner, Boston
Sarah Lightdale
Partner, New York
Megan Browdie
Partner, Washington, DC
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
William Corcoran
Of Counsel, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Ryan Montgomery
Special Counsel, Boston

Clean Hydrogen Startup Monolith Raises More Than $300 Million

July 19, 2022

Cooley advised Monolith, a global leader in clean hydrogen, carbon black and ammonia, on its latest investment round of more than $300 million. Lawyers Laurie Bauer, Michael Rohr and Wilber Barillas led the Cooley team advising Monolith.

Read more

Related contacts

Laurie Bauer
Partner, Chicago
Michael Rohr
Partner, Boston
Grant L. Page
Associate, Los Angeles Santa Monica
Joyce Kim
Associate, Chicago
Jonathan Rivinus
Partner, Colorado
Nyron J. Persaud
Partner, New York
Erica Russell
Associate, San Francisco
Megan Browdie
Partner, Washington, DC
Julia R. Brinton
Associate, Washington, DC

Related Practices & Industries

General Catalyst Leads Olive AI’s $51 Million Financing

May 26, 2022

Cooley advised General Catalyst as the lead investor in Olive AI’s $51 million funding round. Olive AI is a developer of process automation software designed to build meaningful artificial intelligence that empowers and scales humans. Partner Michael Rohr led the Cooley team.

Related contacts

Michael Rohr
Partner, Boston

Related Practices & Industries

General Catalyst Leads Eleanor Health’s $50 Million Series C

May 26, 2022

Cooley advised General Catalyst as lead investor in Eleanor Health’s $50 million Series C funding round. Eleanor Health is a provider of evidence-based outpatient care and addiction recovery services intended to help people suffering from substance abuse disorder. Partners Michael Rohr, Phil Mitchell, William Corcoran and Thomas Connors led the Cooley team.

Related contacts

Michael Rohr
Partner, Boston
Phil Mitchell
Partner, New York
William Corcoran
Of Counsel, Boston
Thomas Connors
Partner, Boston
Colleen Badgley
Partner, Seattle
Patrick Sharma
Associate, Los Angeles Santa Monica
Eric Popp
Associate, Boston
Jennifer Shanley
Special Counsel, New York

Related Practices & Industries

Gopuff Acquires rideOS

June 18, 2021

Cooley advised Gopuff, an on-demand goods, foods and alcohol delivery service, on its acquisition of rideOS, a fleet management platform, for $115 million. Cooley partner Kevin Cooper led the team advising Gopuff on the transaction.

Read more

Related contacts

Kevin Cooper
Partner, New York
Len Jacoby
Partner, New York
Michael Rohr
Partner, Boston
Stephanie Gentile
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Christopher Kimball
Partner, Washington, DC
Adam Dinow
Partner, New York

Related Practices & Industries

View more